Also interesting

Training in Life Sciences: Belgium, the place to be
Belgium is strengthening its strategy to become a European training powerhouse for the Life Sciences industry.

Cell Matters acquired by global leader Cryoport
After a strategic partnership to deliver end-to-end cryopreservation services for leukapheresis derived therapies, Cryoport acquired Cell Matters.

UCB expands innovation footprint with new state-of-the-art gene therapy facility
UCB, a global biopharmaceutical company, today announced it will build an innovative and environmentally sustainable gene therapy process development and clinical manufacturing facility on their high-tech campus in Braine l’Alleud...